Additional TIA AARMNet Pipeline Accelerator Voucher Announced

Press/Media: Press / Media

Description

An additional Therapeutic Innovation Australia (TIA) AARMnet Pipeline Accelerator Voucher was awarded to Dr David Leaver at Charles Sturt University. He will be collaborating with Professor Forwood and Compounds Australia to research new treatments for drug resistance gonorrhoea. The Pipeline Accelerator funding supports research projects targeting antimicrobial resistance (AMR).

Period10 Nov 2022

Media contributions

1

Media contributions

Keywords

  • drug resistance